EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia

Matthias J Müller

Schizophrenia Research and Treatment · 2011

DOI: 10.1155/2011/317368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Research and Treatment, 2011. Verfasst von Matthias J Müller. Beteiligte Einrichtung: Clinic for Psychiatry and Psychotherapy Giessen and Marburg, Vitos Clinical Centre Giessen-Marburg, Academic Teaching Hospital, University of Giessen…. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ziprasidone (ZIP) shows a low propensity for metabolic side effects but can prolong QTc time. It is unclear how these features translate into clinical reality. Charts of inpatients with schizophrenia and switched from ( ZIP − , n = 27 ) or to ZIP ( ZIP + , n = 24 ) were reviewed. Clinical data including documented switch reasons were anonymously analyzed. Comorbidity, body mass index (BMI) at admission, illness severity, side effects, illness duration, and length of stay were comparable in both groups. About 2/3 of ZIP+ were women (1/3 of ZIP − , P = 0.035 ); ZIP+ patients were younger ( P = 0.017 ), had higher BMI values ( P = 0.042 ), and received higher chlorpromazine equivalents before switch ( P = 0.004 ) whereas ZIP doses were comparable (136 versus 141 mg/d). More patients in ZIP − versus ZIP+ were switched because of previous weight gain ( P = 0.006 ) and depression ( P = 0.085 ) whereas single reasons for ZIP − versus ZIP+ were mainly persisting positive symptoms ( P = 0.089 ) and patients' choice ( P = 0.10 ). The results of the naturalistic study corroborate controlled trials.

Autor:innen und Institutionen

  • Clinic for Psychiatry and Psychotherapy Giessen and Marburg, Vitos Clinical Centre Giessen-Marburg, Academic Teaching Hospital, University of Giessen, Licher Strasse 106, 35392 Giessen, Germany.

Zitieren

APA

Müller, M. J. (2011). Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia. Schizophrenia Research and Treatment. https://doi.org/10.1155/2011/317368

Vancouver

Müller MJ. Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia. Schizophrenia Research and Treatment. 2011. doi:10.1155/2011/317368

BibTeX
@article{Mller2011,
  author = {Müller, Matthias J},
  title = {Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia},
  journal = {Schizophrenia Research and Treatment},
  year = {2011},
  doi = {10.1155/2011/317368}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche